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Urinary calcium is a determinant of bone mineral density in
elderly men participating in the InCHIANTI study.
Background. It is generally acknowledged that calcium ex-
cretion is a determinant of bone mineral density. Since data
confirming this hypothesis are not conclusive, the present study
evaluates the relationship between calcium excretion and vol-
umetric bone mineral density (vBMD) in a sample of general
population mostly composed of elderly subjects.
Methods. This relationship was studied in 595 subjects in good
health (M/F 302/293), selected from the InCHIANTI popula-
tion, an epidemiologic survey on aging in Tuscany (Italy). Of
these subjects, 432 (72.6%) were 65 years old or older. Trabecu-
lar and cortical apparent vBMDs were measured by peripheral
quantitative computed tomography at right tibia and standard-
ized to age and body mass index (BMI) in each gender (z-score).
Results. Men in the highest tertile of calcium excretion had
significantly lower trabecular vBMD, and were more likely to
have a trabecular z-score of −1 or less. These results were
confirmed in men older than 64 years, but not in women and
younger men. Sodium excretion and 25-hydroxycolecalciferol
(25(OH)D) were greater in men and women in the highest ter-
tile. No differences among tertiles were observed for cortical
vBMD, circulating levels of interleukin-1b and interleukin-6,
and intake of principal nutrients and calcium. The lower levels
of vBMD z-score were confirmed in men in the highest ter-
tile of calcium excretion, standardized to creatinine clearance,
sodium excretion, plasma calcium, and logarithm of circulating
25(OH)D, and resulted to be associated with calcium excretion
at multiple regression analysis in men.
Conclusion. High calcium excretion is associated with a de-
creased trabecular BMD in elderly men and may predispose
men to trabecular bone loss.
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Osteoporosis is a chronic and potentially invalidating
disorder that negatively influences bone strength, deter-
mining a high risk of bone fractures. Osteoporosis typi-
cally affects postmenopausal or elderly women, but may
also occur in premenopausal women and men at different
ages [1–3]. Bone mass decline in women is accelerated by
the privation of the protective activity provided by estro-
gens [4], but also other factors, like vitamin D deficiency
with secondary hyperparathyroidism, inadequate dietary
calcium intake, or polymorphisms of specific genes [5, 6],
may influence bone mass preservation, predisposing to
osteoporosis. These defects may also contribute to bone
mass loss in men, but the specific causes for male osteo-
porosis remain still unclear [2, 3, 7]. In keeping with these
findings, osteoporosis is considered as a complex disease
with a multifactorial pathogenesis [2, 6].
Elevated calcium excretion is generally included
among the factors predisposing to osteoporosis [2, 7, 8],
but scarce information is available about the relationship
between urinary calcium excretion and bone mineral den-
sity (BMD) in general healthy population. This point has
been mainly explored in osteoporotic or stone-forming
patients with primary hypercalciuria, a defect character-
ized by high calcium excretion without any apparent al-
terations justifying its presence. Primary hypercalciuria
can be detected in 19% of osteoporotic postmenopausal
women [9] or men [7, 8], while it is observed in 5% to
10% of the general population. Among calcium stone-
forming patients primary hypercalciuria is present in 40%
to 50% of cases. Low values of BMD and increased risk
of bone fractures have been observed in hypercalciuric
stone formers [10–17]. A progressive bone loss in stone
formers could result from a urinary calcium excretion ex-
ceeding the amount of calcium absorbed in intestine [11,
18], but could also result from a great ingestion of protein
that increases dietary acid load, thus stimulating calcium
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release from bones and reducing tubular calcium reab-
sorption [11, 17, 18]. Furthermore, an increased produc-
tion of cytokines could enhance calcium excretion and
bone loss stimulating osteoclast activity and bone resorp-
tion [13–15].
The present work was aimed to explore the relation-
ship between calcium excretion and bone density in an
elderly general population. To address this issue, we used
data from InCHIANTI, a population-based epidemio-
logic study on life quality decline in older people, per-
formed in Tuscany, Italy [19]. InCHIANTI is particularly
suited for this purpose because participants were 65 years
old or older, with the exception of a smaller sample of sub-
jects younger than 65 years. Volumetric BMD (vBMD),
estimated by peripheral quantitative computed tomogra-
phy (pQCT) and 24-hour calcium excretion, were mea-
sured in all participants. In addition, nutrient intake and
cytokine serum concentrations were estimated [20].
METHODS
Study population
InCHIANTI is an epidemiologic survey performed in
2 Italian towns located in the Chianti countryside [19]:
Greve in Chianti (11,709 inhabitants; rural area) and
Bagno a Ripoli (4704 inhabitants; suburban area of Flo-
rence). The InCHIANTI population consisted of a ran-
dom sample of the population aged 65 years or older,
living in the 2 catchment areas and selected from the
population registries. In addition, 30 men and 30 women
were randomly selected in each decade between 20 and 65
years and enrolled in the study population. The partici-
pation rate was 69.4% in individuals with age younger
than 65 years, and 91.6% in older subjects. The orig-
inal sample was composed of 1530 subjects, but only
1012 underwent a complete interview, medical examina-
tion, and pQCT assessment, and were resulted to have
correctly collected 24-hour urine. From this sample, we
excluded participants who were or had been under treat-
ment with postmenopausal hormonal replacement ther-
apy (N = 48), diuretics (N = 113), bisphosphonates
(N = 27), steroids (N = 78), vitamin D metabolites
(N = 19), chemotherapies (N = 1), or other drugs af-
fecting calcium metabolism (N = 3). We also excluded
participants with cancer (N = 47), diabetes (N = 96) or
other endocrine disorders (N = 55), renal failure (plasma
creatinine >1.3 mg/dL, N = 28), hypercalcemia (plasma
calcium >2.60 mmol/L, N = 9), chronic hepatitis (N =
6), those who had undergone colon or stomach resection
(N =11), those in bad general condition due to neurologic
disorders or other causes (N = 29), and the women with
early menopause due to surgical ovarian excision (N =
29). After exclusion of these subjects, 595 (M/F 302/293)
were admitted to our study: 432 older than 64 years (M/F
219/213), and 163 younger than 65 years (M/F 83/80).
Participants were divided in 3 percentile groups
(tertiles) according to urinary calcium excretion in each
gender. Individuals below the 33.3rd percentiles were as-
signed to the lowest tertile of calcium excretion (tertile
1; M/F 100/98), those between the 33.3rd and 66.6th per-
centile to the middle tertile of calcium excretion (tertile 2;
M/F 101/98), and those above the 66.6th percentile to the
highest tertile of calcium excretion (tertile 3; M/F 101/97).
Participants were considered hypercalciuric when their
24-hour calcium excretion was greater than 7.5 mmol in
men or 6.25 mmol in women, or greater than 100 lmol/kg
of body weight independent of gender [21].
The InCHIANTI study protocol was approved by the
ethical committee of National Institute of Research and
Care on Aging in Florence. All subjects received an ex-
tensive description of the purposes and known risks of
the study procedures; all gave their informed consent.
Methods
Participants received a prestructured interview, a medi-
cal and functional examination, and extensive testing. At
the end of the interview, the interviewers explained to
the participants and their relatives the correct method
for the 24-hour urine collection, and provided a large
plastic bottle containing 1 g of boric acid as preserva-
tive. The participants were instructed to collect in a bot-
tle all the urine produced in the following 24 hours, and
to make the maximum effort to avoid dispersing urine
during the collection period. Time of start and end of
urine collection and episodes of urine dispersion had
to be annotated in a diary. Participants carried the en-
tire container to the study clinic and were immediately
questioned about possible problems encountered dur-
ing the collection, and any comment was reported in the
database. The urine volume was measured, and 7 aliquots
of 10 mL were stored at −80◦C. Only samples from sub-
jects who reported no episodes of dispersion were taken
into account for this analysis. Height and weight were
measured in each participant, and body mass index (BMI)
was calculated as the weight (kg) divided by the square of
height (m).
Creatinine, calcium, and sodium excretions were mea-
sured in 24-hour urine. Calcium, parathyroid hormone
(PTH), 25-hydroxycolecalciferol (25(OH)D), and cre-
atinine concentrations were measured in plasma. N-
Telopeptide cross-links of the type I collagen (NTx) were
measured in 24-hour urine only in participants from
Greve in Chianti (146 men and 148 women).
Serum levels of 25(OH)D were measured by radioim-
munoassay (DiaSorin, Inc., Stillwater, MN, USA) after
extraction of samples with acetonitrile. Intra- and interas-
say coefficient of variations (CVs) were 8.1% and 10.2%.
Serum intact parathyroid hormone levels (PTH) were
measured using a 2-site immunoradiometric assay (N-tact
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PTHSP; DiaSorin, Inc.). Intra- and interassay CVs were
<3.0 and 5.5%.
Interleukin-6 (IL-6) and interleukin-1b (IL-1b) were
quantified in serum with enzyme-linked immunosorbent
assay (ELISA) methods (Cytoscreen, human IL-6 and
human IL-1b ELISA UltraSensitive; BioSource Inter-
national, Inc., Camarillo, CA, USA). The interassay CV
was 7.0% for all assays. The serum interleukin-6 recep-
tor (IL-6R) level was determined by ELISA method
(Cytoscreen, human sIL-6 R; Biosource International,
Inc.). The serum level of IL-1 antagonist (IL-1ra) was
detected by ELISA method (EASIA ELISA Human IL-
1ra; Biosource International, Inc.).
Urinary N-Telopeptide was measured by ELISA
method (Osteomark Bouty, Milan, Italy) and normalized
to creatinine excretion [nmol of bone collagen equivalent
(BCE)/mmol of creatinine (Cr)]. Intra-assay and interas-
say CVs of the assay were both lower than 8%.
Apparent vBMD was measured by peripheral quanti-
tative computed tomography (pQCT) at the right tibia
(XCT 2000; Stratec Medizintechnik, Pforzheim, Ger-
many). The right leg extended was positioned inside the
gantry of the pQCT device while the subject was seated.
The distal end of the tibia (the tibio-talar joint cleft)
was identified using a pQCT longitudinal scout view,
and was used as an anatomic marker for the identifica-
tion of the measurement sites. The length of the tibia
was assessed as the distance between the medial knee
joint cleft and the medial malleolus identified by manual
palpation in the participant lying supine. Standard 2.5-
mm thick transverse scans were obtained at 4% of the
tibial length, where trabecular bone is the most repre-
sented, and at 38% of the tibial length, where the corti-
cal shell is usually thicker than 2.5 mm, and an accurate
detection of bone boundaries is allowed [22]. The pQCT
cross-sectional images were analyzed using the BonAlyse
software (BonAlyse Oy, Jyvaskyla, Finland), which auto-
matically identifies bone density and geometry in pQCT
scans. Different tissues in the analysis were distinguished
according to different density thresholds: areas with den-
sity values above 710 mg/cm3 were considered as “corti-
cal bone,” while areas with density values between 180
and 710 mg/cm3 were considered as “trabecular bone”
[23]. From the pQCT images we derived: (1) trabecular
vBMD, as the average apparent density of the trabecular
bone area at the 4% site of tibia; (2) cortical vBMD, as the
apparent volumetric density of cortical bone measured at
the 38% site of tibia. Due to the wide range of age and
BMI among the participants, these parameters, measured
by pQCT device as mg/cm3, were expressed in the text as
residuals standardized for age and BMI in each gender
in the whole population (z-score). The population was
divided into 2 groups of vBMD, the first with vBMD z-
score equal to −1 or lower, the other with z-score greater
than −1. The precision error of the XCT2000 is below
1% [23, 24].
Nutritional data were collected using the food-
frequency questionnaire originally developed and val-
idated for the assessment of dietary intake in Italian
volunteers participating in the European Prospective In-
vestigation into Cancer and Nutrition (EPIC) [25]. The
questionnaire was organized in 2 parts, the first focusing
on general dietary habits, the second investigating the fre-
quency of consumption of specific food items or dishes
during the latest year. The EPIC questionnaire was ad-
ministered by trained interviewers, and was analyzed with
software specifically designed for the EPIC-Italy survey
[26].
Statistical analysis
Distribution of categorical variables was compared by
Fisher exact test or by multinomial logistic regression.
The relative risk to have a vBMD z-score equal to −1
or lower was estimated by the calculation of the odds ra-
tio (OR) and 95% confidence intervals (95% CI). Quan-
titative variables were reported in the text as mean ±
standard error. Differences of the means were tested
by Mann-Whitney U test or one-way analysis of vari-
ance (ANOVA) with Bonferroni post-hoc multiple com-
parisons test. The associations of calcium excretion or
vBMD with the other variables were tested by multiple
stepwise regression with R change evaluation for each
variable. Statistical analyses were conducted at the a =
0.05 level and were two-tailed. All analyses were per-
formed using the SPSS 10 statistical package (Chicago, IL,
USA).
RESULTS
In each gender, participants were divided in tertiles
characterized by the highest (range 4.38 to 14 in men and
3.79 to 10.8 mmol/24 hours in women), the middle (range
2.61 to 4.37 in men and 2.15 to 3.76 mmol/24 hours in
women), and the lowest calcium excretion (range 0.32 to
2.58 in men and 0.43 to 2.13 mmol/24 hours in women).
Findings in tertiles are displayed in Table 1. Although
subjects in the highest tertile were younger, trabecular
vBMD z-score was lower in men in the highest tertile
than in those in the lowest tertile. At the opposite, plasma
calcium was greater in men in the highest tertile. Serum
25(OH)D levels were higher in men in the highest than
the middle tertile, and in women in the highest than the
lowest tertile. Sodium excretion was larger in men and
women in the highest tertile. No differences in cortical
vBMD, circulating cytokines, and dietary intake of calo-
ries, principal nutrients, and calcium were found across
tertiles in both genders.
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Table 1. Variables (mean values ± SE) measured in men and women across tertiles of 24-hour calcium excretion
Urinary calcium tertiles
Tertile 1 Tertile 2 Tertile 3 All tertiles
Men
N 100 101 101 302
Age years 70 ± 1.6 65 ± 1.7 61 ± 1.6a 65 ± 0.9
BMI kg/m2 26.4 ± 0.35 27.1 ± 0.31 27.4 ± 0.34 27 ± 0.19
Plasma calcium mmol/L 2.32 ± 0.009 2.35 ± 0.009 2.37 ± 0.008a 2.35 ± 0.005
Plasma PTH pg/mL 23.0 ± 1.09 21.9 ± 0.92 20.3 ± 0.84 21.7 ± 0.55
Serum 25(OH)D nmol/L 56.5 ± 3.23 58.3 ± 2.87 68.7 ± 3.29b 61.2 ± 1.83
Serum IL-6 pg/mL 1.90 ± 0.228 1.83 ± 0.179 1.54 ± 0.136 1.76 ± 0.107
Serum IL-6R ng/mL 99.2 ± 5.06 97.6 ± 5.64 109.3 ± 6.15 102.0 ± 3.26
Serum IL-1b pg/mL 0.22 ± 0.046 0.21 ± 0.049 0.19 ± 0.034 0.21 ± 0.025
Serum IL-1 ra pg/mL 154 ± 10.24 144 ± 10.1 150 ± 10.2 149 ± 5.9
Urinary calcium mmol/24h 1.63 ± 0.063 3.36 ± 0.049 6.11 ± 0.186 3.71 ± 0.126
Urinary sodium mmol/24h 130 ± 5.3 146 ± 5.7 189 ± 7.7c 155 ± 3.9
Urinary NTx nmol BCE/mmol Cr 50 ± 5.3 (45) 45 ± 3.0 (53) 46 ± 2.2 (48) 47 ± 2.1 (146)
Trabecular vBMD z-score 0.19 ± 0.103 0.00 ± 0.095 −0.18 ± 0.098d 0.00 ± 0.057
Cortical vBMD z-score 0.02 ± 0.112 −0.01 ± 0.089 −0.02 ± 0.097 0.00 ± 0.057
Dietary calories kcal/24h 2254 ± 50.1 2421 ± 64.2 2441 ± 61.3 2372 ± 34.2
Calcium intake mmol/24h 22.0 ± 0.70 22.1 ± 0.85 21.1 ± 0.8 22.5 ± 0.45
Protein g/1000 kcal 37.8 ± 0.46 37.0 ± 0.44 38.0 ± 0.47 37.6 ± 0.26
Lipid g/1000 kcal 32.1 ± 0.49 32.5 ± 0.55 32.8 ± 0.53 32.5 ± 0.30
Carbohydrate g/1000 kcal 132.2 ± 1.67 126.8 ± 1.64 127.1 ± 1.62 128.7 ± 0.96
Women
N 98 98 97 293
Age years 72 ± 1.4 66 ± 1.7 60 ± 1.6e 66 ± 0.9
BMI kg/m2 26.5 ± 0.44 26.7 ± 0.39 27.6 ± 0.47 26.9 ± 0.25
Plasma calcium mmol/L 2.36 ± 0.009 2.35 ± 0.008 2.37 ± 0.008 2.36 ± 0.005
Plasma PTH pg/mL 26.4 ± 1.29 22.9 ± 1.10 21.9 ± 1.11f 23.8 ± 0.68
Serum 25(OH)D nmol/L 38.9 ± 2.09 46.4 ± 2.9h 59.3 ± 4.27g 48.2 ± 1.91
Serum IL-6 pg/mL 1.39 ± 0.115 1.33 ± 0.140 1.34 ± 0.195 1.38 ± 0.088
Serum IL-6R ng/mL 99.3 ± 4.81 107.8 ± 6.85 97.7 ± 5.33 101.6 ± 3.31
Serum IL-1b pg/mL 0.20 ± 0.032 0.20 ± 0.033 0.20 ± 0.029 0.28 ± 0.018
Serum IL-1 ra pg/mL 139 ± 9.6 131 ± 8.0 157 ± 9.8 142.4 ± 5.30
Urinary calcium mmol/24h 1.65 ± 0.067 2.9 ± 0.072 5.43 ± 0.172 3.31 ± 0.111
Urinary sodium mmol/24h 111 ± 4.1 128 ± 4.5i 159 ± 5.0c 133 ± 2.9
Urinary NTx nmol BCE/mmol Cr 57 ± 4.4 (45) 65 ± 7.4 (51) 66 ± 6.3 (52) 63 ± 3.6 (148)
Trabecular vBMD z-score 0.05 ± 0.095 −0.08 ± 0.099 0.03 ± 0.108 0.00 ± 0.058
Cortical vBMD z-score 0.04 ± 0.10 −0.03 ± 0.109 −0.01 ± 0.094 0.00 ± 0.058
Dietary calories kcal/24h 1808 ± 42.6 1805 ± 60.0 1911 ± 56.2 1841 ± 30.9
Calcium intake mmol/24h 20.2 ± 0.81 21.5 ± 1.02 20.5 ± 0.78 20.9 ± 0.51
Protein g/1000 kcal 40.6 ± 0.59 39.7 ± 0.51 40.7 ± 0.53 40.3 ± 0.32
Lipid g/1000 kcal 35.1 ± 0.52 35.9 ± 0.61 37.4 ± 0.58 36.1 ± 0.33
Carbohydrate g/1000 kcal 130 ± 1.70 130.7 ± 1.81 124.7 ± 1.75 128.5 ± 1.02
vBMD was measured by pQCT at right tibia, and was expressed as residuals standardized for age and BMI in each gender (z-score). NTx is N-telopeptide cross-links
of the type I collagen; it was measured only in individuals living in Greve in Chianti (their number is between parentheses), and expressed as nmol of bone collagen
equivalent (BCE)/mmol of creatinine (Cr).
aP < 0.001, tertile 3 vs. tertile 1; bP = 0.019 tertile 3 vs. tertile 2; cP = 0.0001, tertile 3 vs. the other two tertiles; dP = 0.023, tertile 3 vs. tertile 1; eP = 0.0001 tertile 3
vs. tertile 1 and 2; fP = 0.021 tertile 3 vs. tertile 1; gP = 0.001 tertile 3 vs. tertile 1; hP = 0.013 tertile 2 vs. tertile 1; iP = 0.025 tertile 2 vs. tertile 1 (one-way ANOVA with
Bonferroni post-hoc test).
Considering men older than 64 years (Table 2), trabec-
ular vBMD z-score and plasma PTH were lower, while
plasma calcium and sodium excretion were greater in
the highest tertile. No differences in trabecular vBMD
were found across tertiles in women older than 64 years
[0.04 ± 0.100 in the lowest (N = 87), −0.11 ± 0.121 in
the middle (N = 73), and 0.06 ± 0.154 in the highest
tertile (N = 53)] and in men or women younger than
65 years.
The percentage of individuals with trabecular vBMD
z-score of −1 or lower (Fig. 1) was increased in the highest
tertile, in men taken as a whole (OR 3.2, CI 95% 1.4 to
7.6, P = 0.008, multinomial logistic regression with the
lowest tertile as the reference group) or aged 65 years or
older (OR 4, 95% CI 1.5 to 11, P = 0.007). Women with
trabecular vBMD z-score of −1 or less were slightly more
frequent in the highest tertile in women aged 65 or older
(OR 2.6, 95% CI 1.6 to 9, P = 0.059).
Twenty-one men (7.0%; age 63 ± 2.9, BMI 27.9 ± 0.91
kg/m2) and 25 women (8.5%; age 60 ± 3.3 years, BMI
27 ± 1.05 kg/m2) were hypercalciuric. All hypercalciurics
were in the highest tertile. Trabecular vBMD of −1 or less
was detected in 7 (33.3%) hypercalciuric and 35 (12.5%)
normocalciuric men (P = 0.016, Fisher exact test; OR
3.5, 95% CI 1.3–9.3), and in 6 (24%) hypercalciuric and
31 (11.6%) normocalciuric women (P = 0.106).
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Table 2. Variables (mean values ± SE) across tertiles of 24 hour calcium excretion in men of 65 years or older
Urinary calcium tertiles
Tertile 1 Tertile 2 Tertile 3 All tertiles
N 80 74 65 219
Age years 76 ± 0.9 73 ± 0.6b 71 ± 0.6a 74 ± 0.4
BMI kg/m2 26.6 ± 0.22 27.3 ± 0.35 27.4 ± 0.40 27.1 ± 0.22
Plasma calcium mmol/L 2.31 ± 0.009 2.34 ± 0.010 2.37 ± 0.009c 2.34 ± 0.006
Plasma PTH pg/mL 23.5 ± 1.28 22.5 ± 1.11 19.4 ± 1.0d 22.0 ± 0.68
Serum 25(OH)D nmol/L 55.5 ± 3.55 56.3 ± 3.37 66.9 ± 3.71 59.1 ± 2.07
Serum IL-6 pg/mL 1.56 ± 0.072 3.36 ± 0.058 6.13 ± 0.257 3.52 ± 0.150
Serum IL-6R ng/mL 127 ± 6.1 147 ± 6.8 186 ± 10.2e 151 ± 4.7
Serum IL-1b pg/mL 50 ± 6.3 (35) 46 ± 3.5 (37) 48 ± 2.8 (33) 48 ± 2.6 (105)
Serum IL-1 ra pg/mL 0.22 ± 0.120 −0.0 ± 0.117 −0.29 ± 0.127f −0.01 ± 0.071
Urinary calcium mmol/24h −0.03 ± 0.135 0.01 ± 0.104 −0.12 ± 0.130 −0.01 ± 0.072
aP = 0.0001, tertile 3 vs. tertile 1; bP = 0.031 tertile 2 vs. tertile 1; cP = 0.0001, tertile 1 vs. tertile 3 and P = 0.036, tertile 3 vs. tertile 2; dP = 0.042 tertile 3 vs. tertile 1;
eP = 0.0001 tertile 3 vs. tertile 1 and P = 0.002 tertile 3 vs. tertile 2; fP = 0.012 tertile 3 vs. tertile 1.
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Fig. 1. Distribution of men with trabecular z-
score of −1 or less across tertiles of calcium
excretion. Tertile 1 is the lowest tertile, tertile
2 the middle, and tertile 3 the highest. vBMD
was measured by pQCT at right tibia, and was
expressed as residuals standardized for age
and BMI in each genders (z-score). The num-
ber of subjects is reported at the base of each
column. ∗OR 3.2, 95% CI 1.4–7.6, P = 0.008,
†OR 4, 95% CI 1.5–11, P = 0.007, §OR 2.6,
95% CI 1–6.9, P = 0.059 (multinomial logistic
regression, tertile 1 as the reference group).
Vezzoli et al: Bone density and calcium excretion 2011
20
18
16
14
12
10
8
6
4
2
0
0 20 40 60 80 100 120 140 160 180 200 220
20
18
16
14
12
10
8
6
4
2
0
0 50 100 150 200 200 250 300 350 400 450
16
14
12
10
8
6
4
2
0
−4     −3     −2     −1     0     1     2     3     4     5
16
14
12
10
8
6
4
2
0
−4     −3     −2     −1     0     1     2     3     4     5
20
18
16
14
12
10
8
6
4
2
0
0   50   100   150   200   250   300   350   400
20
18
16
14
12
10
8
6
4
2
0
0 20 40 60 80 100 120 140 160 180 200 220
Men (N = 302)
R2 = 0.111
P = 0.001
R2 = 0.043
P = 0.001
R2 = 0.025
P = 0.003
R2 = 0.199
P = 0.001
P ns
R2 = 0.031
P = 0.001
Women (N = 293)
Creatinine clearance, mL/min
Urinary sodium excretion, mmol/24 hours
Trabecular tibial vBMD z-score
Ur
in
ar
y 
ca
lci
um
 e
xc
re
tio
n,
 m
m
ol
/2
4 
ho
ur
s
Fig. 2. Relationships of urinary calcium excretion with creatinine clearance, urinary sodium, and trabecular vBMD in men and women. vBMD
was measured by pQCT at right tibia, and was expressed as residuals standardized for age and BMI in each genders (z-score). Results of multiple
stepwise regression (R2 change and significance) are reported for each relationship.
Variables associated with calcium excretion were an-
alyzed by multiple stepwise regression in each gender.
Age, BMI, plasma concentrations of calcium, PTH, IL-
6 and IL-1b , logarithm of plasma 25(OH)D, creatinine
clearance, sodium excretion, trabecular tibial vBMD z-
score, dietary intake of calcium, protein, carbohydrate,
and lipid were independent variables in the model. In
men, creatinine clearance, sodium excretion, plasma cal-
cium concentration, trabecular z-score, and logarithm of
circulating 25(OH)D were associated with calcium ex-
cretion (Table 3). In women, sodium excretion and crea-
tinine clearance were associated with calcium excretion
(Table 3). In order to circumvent possible confounding
effect of the variables indicated by multiple regression
analysis, the relationship between calcium excretion and
bone density was tested after standardization of calcium
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Table 3. Variables associated to calcium excretion (mmol/24h) in stepwise multiple regression model
Variable R2 change R2 change P B P
Men
Creatinine clearance 0.111 0.001 0.017 0.0001
Urinary sodium 0.043 0.001 0.006 0.001
Plasma calcium 0.029 0.002 0.984 0.003
Trabecular BMD z-score 0.025 0.003 −0.352 0.004
Logarithm of plasma 25(OH)D 0.013 0.035 1.131 0.035
Women
Urinary sodium 0.199 0.001 0.014 0.0001
Creatinine clearance 0.031 0.001 0.013 0.001
Age, BMI, plasma concentrations of calcium, PTH, IL-6 and IL1b , logarithm of plasma 25(OH)D, sodium excretion, trabecular tibial vBMD z-score, dietary intake
of calcium, protein, carbohydrate, and lipid as independent variables. Analysis was conducted in each gender separately (260 men and 248 women).
excretion to sodium excretion, creatinine clearance,
plasma calcium, and logarithm of circulating 25(OH)D
in men. vBMD not being considered in the model, the
relative risk of vBMD reduction was calculated in tertiles
of standardized calcium excretion. Ranges were 0.22 to
6.48 in the highest (N = 100; age 66 ± 1.4; BMI 27.3 ±
0.34 kg/m2), −0.44 to 0.2 in the middle (N = 101; age 65
± 1.7; BMI 27.0 ± 0.31 kg/m2), and −2.04 to −0.45 in
the lowest tertile (N = 101; age 64 ± 1.8; BMI 26.7 ±
0.35 kg/m2). Trabecular vBMD z-score was lower in the
highest tertile of calcium excretion residuals, both in the
whole group of men (–0.23 ± 0.101 in the highest tertile,
0.12 ± 0.073 in the middle tertile, and 0.22 ± 0.105 in the
lowest tertile; P = 0.004, the highest vs. the lowest tertile;
one-way ANOVA with Bonferroni post-hoc test), and in
men aged 65 years or older (−0.34 ± 0.121 in the highest
tertile, 0.04 ± 0.107 in the middle tertile, and 0.23 ± 0.142
in the lowest tertile; P = 0.004, the highest vs. the lowest
tertile). Men with trabecular vBMD z-score of −1 or less
were more represented in the highest tertile: they were
8 (7.9%) in the lowest, 11 (10.9%) in the middle, and 23
(23%) in the highest tertile (OR 3.5, 95% CI 1.5–8.2, P =
0.005; multinomial logistic regression, the lowest tertile
as the reference group).
Variables associated with vBMD were tested in each
gender by a multiple stepwise regression model consid-
ering urinary NTx, urinary calcium, and the other factors
used for calcium excretion analysis as independent vari-
ables. In men (N = 146), urinary NTx (R2 change = 0.037,
P = 0.022; B = −0.006, P = 0.023), calcium excretion (R2
change = 0.039, P = 0.019; B = −0.108, P = 0.007), and
age (R2 change = 0.029, P = 0.038; B = −0.009, P =
0.038) were associated with trabecular vBMD. In women
(N = 148), urinary NTx (R2 change = 0.036, P = 0.027;
B = −0.005, P = 0.009) and IL-6 (R2 change = 0.04, P =
0.017; B = 0.109, P = 0.017) were found to be associated.
History of hip fractures was positive in 3 men and
3 females. Four of them presented trabecular z-score
of −1 or less, and 2 of them z-score greater than −1
(OR 13.7, 95% CI 2.5–76, P = 0.004; Fisher exact
test). None of them was in the lowest tertile of calcium
excretion.
DISCUSSION
The relevance of calcium excretion for the preserva-
tion of bone density in men is suggested by our analysis
of participants in InCHIANTI, an Italian epidemiologic
survey on aging. Our findings suggest that high urinary
calcium excretion accelerates the progressive age-related
bone loss in men, without substantial influence on peak
bone mass reached during growth. The negative effect
of calcium excretion was slight in women, probably be-
cause other factors, like estrogen or vitamin D, are pro-
portionally more important than calcium excretion for
bone preservation and for the pathogenesis of osteoporo-
sis [4, 5]. Lack of estrogens is the most effective determi-
nant of BMD reduction in postmenopausal women, and
its effect is not directly dependent from calcium excre-
tion [2]. The levels of 25(OH)D suggest that a vitamin D
deficit is more frequent in InCHIANTI women than men,
especially among women in the lowest tertile of calcium
excretion, in whom it may favor a higher PTH secretion
in comparison with the other tertiles and a probable re-
duction of intestinal calcium absorption [27]. This condi-
tion may negatively influence vBMD, thus contributing
to make us unable to find a negative association between
vBMD and calcium excretion in women [27].
In spite of these results, the number of hip fractures
was not clearly associated with calcium excretion, but the
count of subjects with prevalent hip fractures was too
low to make it easy to detect any significant association
between these variables.
Different from trabecular bone, cortical vBMD was
not related with urinary calcium in our analysis, proba-
bly because the process of endostal resorption reduces
the thickness of cortical bone without detectable mod-
ification of cortical vBMD [28]. This agrees with previ-
ous observations, showing that in hypercalciuric subjects
demineralization is more remarkable at bone sites where
trabecular bone is more represented [11, 12, 17]. Fur-
thermore, we have to consider that pQCT is an accurate
method for the analysis of tibial trabecular bone, but its
accuracy decreases in tibial cortical bone analysis, thus
contributing to explain the lack of relationship between
cortical BMD and calcium excretion [29].
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The low plasma values of PTH and the elevated plasma
concentrations of calcium and 25(OH)D in subjects in the
highest tertile of calcium excretion suggest that urinary
calcium commonly increases as a result of a more active
calcium intestinal absorption, probably stimulated by vi-
tamin D [30]. The increase of serum concentrations of
25(OH)D in InCHIANTI participants with high calcium
excretion is likely to be explained by larger vitamin D
store [31], and may be associated with increased renal
1.25(OH)2D synthesis [16, 32]. This association may be
observed in hypercalciuric stone formers, and has been
attributed to an abnormal renal 25(OH)D hydroxyla-
tion activity [16, 33]. Production of 1.25(OH)2D may
also depend on renal volume, and this may explain the
positive relationship of calcium excretion with creatinine
clearance [33]. However, circulating 1.25(OH)2D was not
measured in InCHIANTI population due to the normal
levels of 1.25(OH)2D we previously found in hypercal-
ciuric stone formers [34]. Although 100-fold less active
than 1.25(OH)2D, 25(OH)D may have a biological ac-
tivity due to its 1000-fold higher serum concentration.
The rise of 25(OH)D may enhance calcium excretion and
blood calcium concentrations, and may have a protec-
tive effect on BMD as a result of the negative relation-
ship between serum levels of 25(OH)D and PTH [27]. In
spite of this setting, vBMD was low in men with high
calcium excretion, similar to that previously reported
in absorptive hypercalciuria [11, 12, 16]. It may be at-
tributed to a negative calcium balance induced by kid-
ney inability to decrease calcium excretion during fasting
or low calcium diet [11, 18, 35]. This especially occurs
when diet is poor of milk and dairy products, so that cal-
cium intake falls under 5 mmol a day [11, 30]. In ad-
dition, quantitative or qualitative differences in sodium,
carbohydrate, protein, or lipid intake can influence cal-
cium absorption and bone calcium metabolism [32, 36–
38]. Among them, only sodium ingestion, estimated by
us with the measurement of urinary sodium excretion, is
increased in InCHIANTI subjects with high calcium ex-
cretion. Sodium intake can influence calcium metabolism
at different levels. The tubular sodium load following di-
etary sodium ingestion can decrease tubular calcium re-
absorption; thus, it may favor a reduction of BMD when
persistent in time [11, 18]. However, sodium-induced cal-
cium excretion may also stimulate 1.25(OH)2D synthesis
and intestinal calcium absorption with a positive effect
on BMD [36]. In addition, it may be that dietary sodium
load promotes intestinal absorption of calcium by stim-
ulating its transport across mucosa. Therefore, whereas
sodium intake appears as a determinant of calcium ex-
cretion, its consequences on BMD probably change in
relation to the characteristics of dietary habits, intestinal
absorption, and tubular reabsorption capability in single
individuals. In agreement with this hypothesis, no rela-
tionships between BMD and sodium excretion were ob-
served in InCHIANTI population [38]. In the light of our
results, intake of calcium or other nutrients does not ap-
pear able to sustain the reduction of BMD in subjects
with high calcium excretion, even though daily balance
between excreted and absorbed calcium may be more
frequently negative in them.
Alternatively, the reduction of bone density may be at-
tributed to a mechanism in which the defect responsible
of high calcium excretion directly involves bone tissue
and predisposes to bone loss [12, 16, 39]. An increased
production of cytokines may lead to osteoclast activa-
tion, bone loss, and urinary calcium wastage. Evidence of
this was the more active production of IL-1b by mono-
cytes cultured from stone-forming patients with fasting
hypercalciuria [13, 14]. Controversial results were instead
obtained about IL-6, whereas an alteration of cytokine
synthesis was not observed in absorptive hypercalciuria
[13–15]. We did not find any differences of blood con-
centrations of cytokines, IL-6R and IL-1ra, in individuals
with different calcium excretion or vBMD, even though
the levels of IL-6 appeared to be associated to vBMD
in women. However, we did not identify subjects with
fasting hypercalciuria; moreover, circulating levels of IL-
1b and IL-6 could not be representative of the amount
of cytokines produced by osteoblasts in their remodeling
activity.
CONCLUSION
Findings in InCHIANTI display that BMD is more
frequently reduced in men with high calcium excre-
tion, though they were not necessarily hypercalciuric.
Although we cannot exclude the role of cytokines or
negative calcium balance, a specific and probably ge-
netic defect of calcium metabolism may be expressed
in bones, as well as in other calcium-handling tissues,
and may favor bone demineralization in subjects with
high calcium excretion [40]. To our knowledge, this is
the first population-based study in which calcium excre-
tion arises as a determinant of bone mineralization. Early
measurements of calcium excretion could help to detect
men predisposed to losing bone mass and to developing
osteoporosis.
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